174 related articles for article (PubMed ID: 30050301)
21. Working memory dysfunction associated with brain functional deficits and cellular metabolic changes in patients with generalized anxiety disorder.
Moon CM; Sundaram T; Choi NG; Jeong GW
Psychiatry Res Neuroimaging; 2016 Aug; 254():137-44. PubMed ID: 27442922
[TBL] [Abstract][Full Text] [Related]
22. Frontal lobe metabolic alterations characterizing Parkinson's disease cognitive impairment.
Chaudhary S; Kumaran SS; Goyal V; Kalaivani M; Kaloiya GS; Sagar R; Mehta N; Srivastava AK; Jagannathan NR
Neurol Sci; 2021 Mar; 42(3):1053-1064. PubMed ID: 32729012
[TBL] [Abstract][Full Text] [Related]
23. [Regional effects of age and sex in magnetic resonance spectroscopy].
García Santos JM; Fuentes LJ; Vidal JB; Antequera M; Torres Del Río S; Antúnez C; Ortega G
Radiologia; 2010; 52(4):342-50. PubMed ID: 20557913
[TBL] [Abstract][Full Text] [Related]
24. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.
Reneman L; Majoie CB; Flick H; den Heeten GJ
AJNR Am J Neuroradiol; 2002 Feb; 23(2):231-7. PubMed ID: 11847047
[TBL] [Abstract][Full Text] [Related]
25. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
Strzelecki D; Podgórski M; Kałużyńska O; Gawlik-Kotelnicka O; Stefańczyk L; Kotlicka-Antczak M; Gmitrowicz A; Grzelak P
Nutrients; 2015 Oct; 7(10):8767-82. PubMed ID: 26506383
[TBL] [Abstract][Full Text] [Related]
26. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
[TBL] [Abstract][Full Text] [Related]
27. Multimodal neuroimaging based classification of autism spectrum disorder using anatomical, neurochemical, and white matter correlates.
Libero LE; DeRamus TP; Lahti AC; Deshpande G; Kana RK
Cortex; 2015 May; 66():46-59. PubMed ID: 25797658
[TBL] [Abstract][Full Text] [Related]
28. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W
Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302
[TBL] [Abstract][Full Text] [Related]
29. Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders.
Endo T; Shioiri T; Kitamura H; Kimura T; Endo S; Masuzawa N; Someya T
Biol Psychiatry; 2007 Nov; 62(9):1030-7. PubMed ID: 17631869
[TBL] [Abstract][Full Text] [Related]
30. Effects of donepezil on brain morphometric and metabolic changes in patients with Alzheimer's disease: A DARTEL-based VBM and (1)H-MRS.
Moon CM; Kim BC; Jeong GW
Magn Reson Imaging; 2016 Sep; 34(7):1008-16. PubMed ID: 27131829
[TBL] [Abstract][Full Text] [Related]
31. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
[TBL] [Abstract][Full Text] [Related]
32. Altered white matter metabolism in delayed neurologic sequelae after carbon monoxide poisoning: A proton magnetic resonance spectroscopic study.
Kuroda H; Fujihara K; Mugikura S; Takahashi S; Kushimoto S; Aoki M
J Neurol Sci; 2016 Jan; 360():161-9. PubMed ID: 26723994
[TBL] [Abstract][Full Text] [Related]
33. Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a (1)H-MRS study.
Brown MS; Singel D; Hepburn S; Rojas DC
Autism Res; 2013 Feb; 6(1):1-10. PubMed ID: 23166003
[TBL] [Abstract][Full Text] [Related]
34. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
[TBL] [Abstract][Full Text] [Related]
36. Proton magnetic resonance spectroscopy: normal findings in the cerebellar hemisphere in childhood.
Costa MO; Lacerda MT; Garcia Otaduy MC; Cerri GG; Da Costa Leite C
Pediatr Radiol; 2002 Nov; 32(11):787-92. PubMed ID: 12389106
[TBL] [Abstract][Full Text] [Related]
37. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
[TBL] [Abstract][Full Text] [Related]
38. Proton Chemical Shift Imaging of the Brain in Pediatric and Adult Developmental Stuttering.
O'Neill J; Dong Z; Bansal R; Ivanov I; Hao X; Desai J; Pozzi E; Peterson BS
JAMA Psychiatry; 2017 Jan; 74(1):85-94. PubMed ID: 27893013
[TBL] [Abstract][Full Text] [Related]
39. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.
Yildiz-Yesiloglu A; Ankerst DP
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):969-95. PubMed ID: 16677749
[TBL] [Abstract][Full Text] [Related]
40. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.
Cecil KM; DelBello MP; Sellars MC; Strakowski SM
J Child Adolesc Psychopharmacol; 2003; 13(4):545-55. PubMed ID: 14977467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
